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The amino acid substitutions in subunit 6 of the mitochondrial ATPase complex have been determined for 
4 oligomycin resistant mutants of Saccharomyces cerevisiae. The data were obtained for each mutant by 
nucleotide sequence analysis of the mitochondrial oli2 gene. Amino acid substitutions conferring oligomycin 
resistance in subunit 6 are located in two conserved regions that are thought to form domains which span 
the inner mitochondrial membrane. The disposition of these amino acid substitutions is consistent with the 
view that these two membrane-spanning domains interact structurally and functionally with the DCCD- 
binding proteolipid subunit 9 in the F,-sector. 
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1. INTRODUCTION 
The oli2 gene in mitochondrial DNA (mtDNA) 
of Saccharomyces cerevisiae codes for subunit 6 
(predicted length 259 amino acids) of the proton 
translocating mitochondrial ATPase complex. 
Together with subunit 6, subunits 8 and 9 (encoded 
by the mitochondrial aapl and olil genes, respec- 
tively) constitute the membrane-bound Fo-sector of 
the mtATPase complex [ 11. Subunit 6 has been im- 
plicated [2] in the coupling of proton translocation 
to ATP synthesis catalyzed by the soluble Ft-sector 
of the complex. The translocation of protons is 
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generally considered [3] to be primarily effected by 
subunit 9, the 76 amino acid DCCD-binding pro- 
teolipid; it has further been suggested [4,5] that 
subunit 6 may itself play a role in this process. 
From a genetic perspective, the oli2 gene was in- 
itially identified as one of the loci in mtDNA at 
which resistance to oligomycin was determined [6]. 
This locus was shown to be separate from the other 
such mitochondrial locus, now known as olil [7], 
on the basis of genetic recombination studies [8,9] 
and physical mapping by petite deletion analysis 
[lo]. The existence of a further locus determining 
an oliR phenotype, designated oli4, was proposed 
[l l] on the basis of the observed low, but signifi- 
cant recombination frequency with a reference oli2 
mutant. 
In contrast to the situation with the olil gene, 
where more than fifteen oliR mutants have been 
subjected to amino acid or nucleotide sequence 
analysis [7,12,13], only three oliR mutants mapp- 
ing in the oli2 region have been analyzed at the 
DNA sequence level. Each such mutation leads to 
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a single amino substitution near the C-terminus of 
subunit 6, at residues 171, 175 and 232, respective- 
ly [ 14,151. The substitution at residue 232 was 
identified in a strain reportedly carrying an allele 
of the oli4 locus [14]. 
In this communication we report the changes in 
the oli2 gene of 4 further oliR mutants. The data 
extend the information on amino acid substitu- 
tions in subunit 6 conferring oligomycin resistance. 
The disposition of these amino acid substitutions 
provides evidence for interactions between 
membrane-spanning domains of subunit 6 and the 
subunit 9 proteolipid in the Fo-sector. In addition, 
one of these strains which suffers a concomitant 
impairment in mtATPase function provides fur- 
ther insight into regions of subunit 6 critical to 
energy transduction in the Fo-sector. 
2. MATERIALS AND METHODS 
2.1. Strains 
The strains analyzed here are listed in table 1, 
which shows the original denotation of the 
mitochondrial mutation leading to oligomycin 
resistance. In addition, a more systematic designa- 
tion of the particular allele number is given for 
each mutation, in line with current usage. 
2.2. Methods 
Growth of strains, mtDNA extraction [16] and 
nucleotide sequence determination of the ofi gene 
[l7] were carried out as described. 
3. RESULTS AND DISCUSSION 
3.1. Strategy for characterization of oliR mutants 
Most of the oli2 mutants analyzed in this work 
come from the same collection of oliR mutants 
from which Nagley et al. [13] have previously 
selected strains characterized for their olil muta- 
tions. Briefly, this collection was derived by 
manganese mutagenesis [18] of the parent rho+ 
strain J69-1B. Those oliR isolates showing 
mitochondrial inheritance were subsequently 
classified as oli2 mutants on the basis of low 
recombination frequencies (< 1070) in crosses with 
the definitive oli2 oliR strain D22/A15 [8]. This 
reference strain D22/A15 was also subjected to 
nucleotide sequence analysis in this work. 
The complete nucleotide sequence of the oli2 
gene in each of the 4 mutant strains (table 1) was 
determined as it was for oli2 mit- strains [17]. The 
entire sequence of 780 nucleotides of the oli2 gene 
was obtained by the dideoxy method using the ap- 
propriate set of three oli2-specific synthetic 
primers on M 13-derived single-stranded templates 
t171. 
3.2. Sequence changes in oliR mutants 
The single nucleotide changes observed relative 
to the J69- 1B wild-type sequence [ 151, together 
with the consequent amino acid substitutions, are 
shown in table 1. Isolate 0817 has an amino acid 
substitution (IlerTi -+ Met) identical to the one 
previously identified in the independently derived 
strain D273-lOB/A48 [14] (table 2). However, 
Table 1 
Nucleotide sequence changes in the oli2 gene and resulting amino acid substitutions in oligomycin resistant strains 
analyzed in this work 
Strain Allele designation Nucleotide Codon changeb Amino acid Source Comment 
change= residue change 
Previous Current 
0817 - oIi2-17 T-G (513) ATT-+ATG (171) Ile-rMet MonashC Reduced growth rate 
0836 - oli2-36 T-‘A (523) TCT+ACT (175) Ser-+Thr Monashc 
0858 - oli2-58 C-‘A (524) TCT+TAT (175) Ser+Tyr Monashc Heat-sensitive 
strain C58 [2] 
D22/A15 OL oIi2-144 C+G (524) TCT+TGT (175) Ser+Cys 161 Denoted On in [8] 
a Nucleotide sequence numbers are specified with reference to fig.3 of [15] 
b Codon numbers are specified with reference to fig.5 of [14] 
’ The strains are from a collection of oliR mutants derived by MnClz mutagenesis of strain J69-1B [13] 
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Table 2 
Nucleotide sequence changes in the oli2 gene and resulting amino acid substitutions in oligomycin resistant strains 
previously analyzed 
Strain Allele designation Nucleotide Codon change Amino acid Reference Comment 
change residue 
Previous Current change 
D273-lOB/A48 Oh8 oli2-118 T+G (513) ATT+ATG (171) He-Met ]I41 Denoted ok? in [14] 
D273-lOB/Al6 O&t oli2-622 A-T (696) TTA-rTTT (232) Leu+Phe (141 Denoted oli-4 in f14] 
70M oIi2-23r oli2-23 T+A (523) TCT+ACT (175) Ser-+Thr 1151 Denoted oli23-r 
in [19] 
Nucleotide and codon numbering as in table 1 
unlike the latter strain, 0817 suffers a concomitant 
impairment in mitochondrial function manifested 
in its ability to grow only slowly on non- 
fermentable substrates uch as ethanol. This obser- 
vation may reflect a specific interaction between 
the nuclear genome of J69-IB and this particular 
mitochondrial allele (of the type described [13]), or 
alternatively there may be a second mutation in 
either the mtDNA or nuclear genomes of this 
isolate. This aspect has not been further in- 
vestigated. 
The other substitutions in oliR mutants were all 
found to occur at the same amino acid residue 
SerlTs. Isolate 0836 carries a threonine residue at 
this position, which arises from precisely the same 
nucleotide substitution as previously observed in 
strain 70M [15] (table 2). The allele in strain 70M, 
oli2-23, originates from an oliR isolate of J69-IB 
(0823) (cf. [19,20]); the nucleotide change in the 
oli2 gene of isolate 0823 has also been directly con- 
firmed by the methods reported in this paper (not 
shown). 
On the other hand, in isolate 0858 the substitu- 
tion Seri75 ---+ Tyr confers oligomycin resistance, 
with a concomit~t reduced growth on the 
substrate ethanol at 28°C and an even more 
marked heat sensitivity (no growth at 36°C on 
ethanol media). This impairment in respiratory 
growth has been shown to result from an ineffi- 
cient coupling of respiration to ATP synthesis in 
mito~hondria 121. A further isolate, 0803, which 
has almost identical genetic and biochemical prop- 
erties to those of 0858 [2,15], was shown to carry 
precisely the same mutation as 0858 (not shown). 
These strains may not, however, have been in- 
dependent isolates (R.M. Hall, personal com- 
munication). 
Finally, the definitive o/i2 mutant D221A15 was 
found to carry the substitution Serr;rs -+ Cys. 
This mutation is 10 nucleotides away from the 
mutation denoted ok-2 by Macino and Tzagoloff 
[14] (table 2), and would be consistent with the 
assignation of both mutations to the same locus, 
due to the failure to observe recombinants between 
them (1121; cf. [IS]). 
The only other oli2 oliR mutation for which se- 
quence data are available (table 2) is that denoted 
oli-4 by Macino and Tzagoloff [14] (Leuzsz -+ 
Phe) which lies some 180 bases away from the 
cluster of other mutations considered here. Unfor- 
tunately, no sequence data are available on the 
reference oli4 strain characterized genetically by 
Clavilier [ 111. 
Since the mutations described here in molecular 
terms clearly all lie within the oli2 gene, there 
seems no compelling reason not to denote each of 
them alleles of the oli2 locus, as suggested in tables 
1 and 2. This is consistent with the unified 
nomenclature proposed for oliR mutations in the 
ofil gene [7]. It would also seem desirable to con- 
sider renaming other mutations conferring an- 
tibiotic resistance reportedly closely linked to the 
so-called oli2 and oli4 loci, such as ossl [21], if 
nucleotide sequence analysis demonstrates the 
mutational site to lie within the oli2 gene. 
3.3. delineation of domains in subunit 6 involved 
in o~igomyc~n resistance 
The known amino acid substitutions in subunit 
6 leading to the oliR phenotype (tables 1 and 2) are 
confined to two previously identified [15] evolu- 
tionarily conserved regions of this protein (fig.1). 
These two relatively short regions of amino acid se- 
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keglo” I Region II 
160 180 240 
J69-1B WPAGT PLPLYPLLYI XTLSVIARi ISLGLRLGSN ILAGHLL lLEFA.lGIiO SYVWTILTAS NY.0 
17,11~--~-- ~__- 
2X.36---- T ______ 
144 
,P __- 
--- +-_- 
,‘,ll-:,,j __ __ ~ _-_F---_h__ 
Fig. 1. Disposition of substitutions conferring 
oligomycin resistance in two evolutionarily conserved 
regions of subunit 6. Regions I and II, delineated in [151 
extend from amino acid residues 155-197, and 231-254, 
respectively. Allele numbers of oli2 oIiR mutants are 
indicated at the left. The relevant amino acid 
substitutions (tables 1 and 2) are indicated within the 
horizontal lines representing wild-type sequence. Allele 
01~~58 confers a partial mit- phenotype (see text). The 
substitutions [17] in a mit- strain Ml l-28 are also 
indicated. 
quence correspond closely to the 4th and 5th 
transmembrane a-helices in a structure proposed 
for subunit 6, in which 5 transmembrane spans are 
predicted [4] (see fig.2). In this folding scheme the 
amino acid substitutions conferring the oliR 
phenotype occur exclusively in these adjacent 
membrane spanning domains (fig.2). 
3.4. Evidence for structural and functional 
interaction of subunits 6 and 9 
Oligomycin is an antibiotic which inhibits 
mtATPase function by preventing the transloca- 
tion of protons through the Fo-sector. Evidence 
from radiochemical abelling studies is interpreted 
to suggest that the primary binding site for 
oligomycin lies within subunit 9 [22,23]. This raises 
the question of how amino acid substitutions in 
subunit 6 confer resistance to oligomycin, if indeed 
oligomycin does not bind to subunit 6 directly. The 
occurrence of oli2 oliR mutations can be rational- 
ised if subunits 6 and 9 are intimately associated in 
the membrane. The altered subunit 6 structure in 
the oliR mutants could then allosterically alter the 
oligomycin binding site of subunit 9 (cf. [5,7]). 
This could be mediated, for example, by direct in- 
teraction of the transmembrane domains 
represented in fig.2. 
Current concepts of the topological organization 
[4,5] of the Fo-sector of the E. coli proton- 
translocating ATPase complex place emphasis on 
dynamic structural and functional interactions be- 
82 
SUBUNIT 6 SUBUNIT 9 
I I I I 
Fig.2. Location of amino acid substitutions conferring 
oligomycin resistance in membrane-spanning domains 
of mtATPase subunit 6 and 9. Vertical lines represent 
the 4th and 5th transmembrane helices [4] of subunit 6, 
and the two transmembrane helices of subunit 9 [3]. The 
length of a transmembrane span is taken to be 25 amino 
acid residues [4]. Data for amino acid substitutions 
leading to the oliR phenotype are compiled for subunit 
6 (tables 1 and 2), and subunit 9 ([7,12,13]; T.A. Wilson 
and P. Nagley, unpublished). The position of the 
DCCD-binding residue Glusp is shown. Asterisk 
indicates the location of the critical amino acid 
substitution (Thr24s - Lys) in the mit- strain Mll-28 
(see text and fig.1). 
tween subunits a and c (homologous to yeast 
subunit 6 and 9, respectively), although the precise 
relative orientation of these subunits is still con- 
troversial. In one such proposal [4] the am- 
phipathic 4th transmembrane helix of subunit a is 
juxtaposed with the C-terminal stem of subunit c 
and may constitute the proton pore. Applying this 
scheme to the yeast Fo-sector, the translocation of 
protons could involve an array of polar amino 
acids in region I (fig.1) of subunit 6 (the left-hand 
stem of subunit 6, fig.2) and the DCCD-binding 
Glu59 of subunit 9 (in its right-hand stem, fig.2). 
Evidence that the two transmembrane helices of 
subunit 6 (fig.2) may indeed play a direct role in 
energy transduction arises from the identification, 
in each of these helices, of amino acid substitutions 
that compromise mtATPase function. In con- 
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I the deleterious effects of 
- Tyr in 
In conserved 
II (right-hand of subunit 6, fig.%) we 
have 
- Lys) (cf. figs and 2) in a mit- mutant 
Ml l-28, that is unable to synthesize ATP in- 
tramitochondrially. Further work will be required 
to establish the role of this 5th transmembrane 
helix in energy transduction and its interaction 
with other membrane domains in the Fo-sector. 
ACKNOWLEDGEMENTS 
This work was supported by the Australian 
Research Grants Scheme. We thank Professor 
A.W. Linnane for useful discussions. 
REFERENCES 
[l] Linnane, A.W., Lukins, H.B., Nagley, P., 
Marzuki, S., Hadikusumo, R.G., Jean Francois, 
M.J.B., John, U.P., Ooi, B.G., Watkins, L.C., 
Willson, T.A. and Meltzer, S. (1985) in: 
Achievements and Perspectives of Mitochondrial 
Research (Quagliariello, E. et al. eds) 
Bioenergetics, vol.1, pp.21 l-222, Elsevier, 
Amsterdam, New York. 
121 Murphy, M., Roberts, H., Choo, W.M., 
Macreadie, I.G., Marzuki, S., Lukins, H.B. and 
Linnane, A.W. (1980) Biochim. Biophys. Acta 592, 
431-444. 
[3] Sebald, W. and Hoppe, J. (1981) Curr. Top. 
Bioenerg. 12, l-64. 
[4] Cox, G.B., Fimmel, A.L., Gibson, F. and Hatch, 
L. (1986) Biochim. Biophys. Acta 849, 62-69. 
[5] Hoppe, J. and Sebald, W. (1986) Biochimie 68, 
427-434. 
[6] Avner, P.R. and Griffiths, D.E. (1973) Eur. J. Bio- 
them. 32, 312-321. 
171 
PI 
t91 
1101 
1111 
WI 
iI31 
u41 
WI 
1161 
1171 
iI81 
v91 
WI 
WI 
Ooi, B.G., Novitski, G.E. and Nagley, P. (1985) 
Eur. J. Biochem. 152, 709-714. 
Avner, P.R., Coen, D., Dujon, B. and Slonimski, 
P.P. (1973) Mol. Gen. Genet. 125, 9-52. 
Trembath, M.K., Molloy, P.L., Sriprakash, K.S., 
Cutting, G.J., Linnane, A.W. and Lukins, H.B. 
(1976) Mol. Gen. Genet. 145, 43-52. 
Choo, K.B., Nagley, P., Lukins, H.B. and 
Linnane, A.W. (1977) Mol. Gen. Genet. 153, 
279-288. 
Clavilier, L. (1976) Genetics 83, 227-243. 
Sebald, W., Wachter, E. and Tzagoloff, A. (1979) 
Eur. J. Biochem. 100, 599-607. 
Nagley, P., Hall, R.M. and Ooi, B.G. (1986) FEBS 
Lett. 195, 159-163. 
Macino, G. and Tzagoloff, A. (1980) Cell 20, 
507-517. 
Novitski, C.E., Macreadie, LG., Maxwell, R.J., 
Lukins, H.B., Linnane, A.W. and Nagley, P. 
(1984) Curr. Genet. 8, 135-146. 
Bingham, C.G. and Nagley, P. (1983) Biochim. 
Biophys. Acta 740, 88-98. 
John, U.P., Willson, T.A., Linnane, A.W. and 
Nagley, P. (1986) Nucleic Acids Res., in press. 
Putrament, A., Baranowska, G.M. and Prazmo, 
W. (1973) Mol. Gen. Genet. 126, 357-366. 
Murphy, M., Choo, K.B., Macreadie, I.G., 
Marzuki, S., Lukins, H.B., Nagley, P. and 
Linnane, A.W. (1980) Arch. Biochem. Biophys. 
203, 260-270. 
Ooi, B.G. and Nagley, P. (1986) Curr. Genet. 10, 
713-723. 
Lancashire, W.E. and Mattoon, J.K. (1979) Mol. 
Gen. Genet. 176, 255-264. 
[22] Enns, R.K. and Criddle, R.S. (1977) Arch. Bio- 
them. Biophys. 182, 587-600. 
[23] Sebald, W., Gatti, D., Weber, H. and Hoppe, J. 
(1985) in: Achievements and Perspectives of 
Mitochondrial Research (Quagliariello, E. et al. 
eds) Bioenergetics, ~01.1, pp.27-34, Elsevier, 
Amsterdam, New York. 
83 
